Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
155,892
Value
$5.28M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026155,892$5.28M<0.1%−26,073−14.3%ReducedHolders
Q1 2026181,965$5.48M<0.1%+129,497+246.8%AddedHolders
Q4 202552,468$1.64M<0.1%+42,694+436.8%AddedHolders
Q3 20259,774$197.4K<0.1%+13+0.1%AddedHolders
Q2 20259,761$163.6K<0.1%−1,051−9.7%ReducedHolders
Q1 202510,812$166.2K<0.1%+656+6.5%AddedHolders
Q4 202410,156$223.8K<0.1%+524+5.4%AddedHolders
Q3 20249,632$173.6K<0.1%−13,404−58.2%ReducedHolders
Q2 202423,036$374.3K<0.1%+14,846+181.3%AddedHolders
Q1 20248,190$115.6K<0.1%+4,362+113.9%AddedHolders
Q4 20233,828$40.0K<0.1%+1,023+36.5%AddedHolders
Q3 20232,805$28.6K<0.1%+980+53.7%AddedHolders
Q2 20231,825$13.7K<0.1%−8,295−82.0%ReducedHolders
Q1 202310,120$89.6K<0.1%−427−4.0%ReducedHolders
Q4 202210,547$96.2K<0.1%−158−1.5%ReducedHolders
Q3 202210,705$87.0K<0.1%+511+5.0%AddedHolders
Q2 202210,194$77.0K<0.1%−1,139−10.1%ReducedHolders
Q1 202211,333$106.0K<0.1%−365−3.1%ReducedHolders
Q4 202111,698$94.0K<0.1%+182+1.6%AddedHolders
Q3 202111,516$112.0K<0.1%−991−7.9%ReducedHolders
Q2 202112,507$124.0K<0.1%−1,960−13.5%ReducedHolders
Q1 202114,467$167.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.